PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $67,362 | -45.2% | 14,122 | +0.0% | 0.00% | – |
Q4 2022 | $122,818 | -38.3% | 14,117 | -15.8% | 0.00% | – |
Q3 2022 | $199,000 | +32.7% | 16,766 | +59.1% | 0.00% | – |
Q2 2022 | $150,000 | -27.5% | 10,540 | +17.9% | 0.00% | – |
Q4 2021 | $207,000 | -20.4% | 8,942 | +2.4% | 0.00% | – |
Q3 2021 | $260,000 | -15.3% | 8,736 | -3.0% | 0.00% | – |
Q2 2021 | $307,000 | +23.8% | 9,004 | +123.6% | 0.00% | – |
Q4 2020 | $248,000 | – | 4,027 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |